News Verve Ventures interview with CEO Karsten Lindhardt October 8, 2024 Read more Press Release: Biograil and CSL Sign Collaboration Agreement for development of certain CSL compounds using Biograil’s proprietary BIONDD™ technology. July 17, 2024 Read more Biograil presents at TIDES USA May 17, 2024 Read more Presentation of student project "Assessment of barriers towards oral treatment of autoimmune diseases with adalimumab" March 7, 2024 Read more Biograil presents at CEO & Investor Conference in New York City February 27, 2024 Read more Biograil CTO and Industrial Postdoc present at APPSComms PharmsSci 360 October 22, 2023 Read more Press Release: Biograil and Lilly Sign Collaboration and License Agreement October 4, 2022 Read more Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDD™ in Preparations for Phase 1 clinical trials March 14, 2022 Read more Press Release: Biograil Forms International Scientific Advisory Board March 1, 2022 Read more Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics February 17, 2022 Read more Press Release: Biograil signs collaboration agreement with Janssen December 2, 2020 Read more Press Release: Biograil announces – Sanner Ventures has joined Investor Syndicate April 30, 2020 Read more CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST April 8, 2020 Read more Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables January 15, 2020 Read more
